ACE Market’s Malaysian Genomics Resource Centre Bhd (Malaysian Genomics) saw its fourth quarter revenue grow 57 percent to RM2.91 million, following its consolidation of its now wholly-owned subsidiary MPath Sdn Bhd.
Net profit increased to RM335,000 for the fourth quarter ended June 30 2017 compared to the corresponding quarter last year, driven by a gain from acquiring a further 50 percent stake in MPath Sdn Bhd. MPath owns the country’s fourth largest independent chain of pathology laboratories, Clinipath (Malaysia) Sdn Bhd.
Sunway Berhad, the holding company of one of Malaysia’s largest conglomerates, the Sunway Group, is set to explore new avenues of growth in keeping with the changing business landscape, while expanding its portfolio of core businesses domestically and regionally.
“Our current businesses are doing well but we are fully aware that we need to find new horizons if we are to continue to thrive in the decades ahead.
Ekovest Bhd, a Bursa Malaysia Main Market listed company involved in construction, property development and infrastructure concession businesses, announced a gross profit of RM98.97 million for its 4th quarter financial year ended 30 June 2017 (4QFY2017), representing a 67% increase from RM59.16 million in the corresponding period last year. Its revenue stood at RM318.45 million, a 9.4% increase as compared to RM291.07 million a year ago.
A filing to Bursa Malaysia shows that the increase in the revenue and profit for the reporting quarter was mainly due to the due to higher revenue contribution from the construction segment.